ConductScience.org, home

Trial · NCT03452488

Outcomes12

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYChange From Baseline to 6 Months in Gait Speed for 400 Meter Walking (MW) TestBaseline and 6 Months
Full Analysis Set: The Full Analysis Set (FAS) population consists of randomized participants, excluding participants who failed to take at least one dose of trial medication and had a very early withdrawal (first week after randomization) definitely not related to study medication and lacked any post randomization data. Participants with data available were included.~One participant randomized but not treated with 175 mg BIO101.
Meter/Second (m/s)LEAST_SQUARES_MEAN
SECONDARYChange From Baseline to 6 Months in Short Form-36 (SF-36) 10 Item Physical Function Domain (PF-10) Sub-scoreBaseline and 6 Months
Full Analysis Set: Population consists of randomized participants, excluding participants who failed to take at least one dose of trial medication and had a very early withdrawal (first week after randomization) definitely not related to study medication and lacked any post randomization data. Participants with data available were included.
score on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline to 6 Months in Handgrip Strength TestBaseline and 6 Months
Full Analysis Set: Population consists of randomized participants, excluding participants who failed to take at least one dose of trial medication and had a very early withdrawal (first week after randomization) definitely not related to study medication and lacked any post randomization data. Participants with data available were included.
kilograms (Kg)LEAST_SQUARES_MEAN
SECONDARYChange From Baseline to 6 Months in Appendicular Lean Body Mass (ALM) Based on Dual-energy X-ray Absorptiometry (DEXA) MeasurementsBaseline and 6 Months
Full Analysis Set: Population consists of randomized participants, excluding participants who failed to take at least one dose of trial medication and had a very early withdrawal (first week after randomization) definitely not related to study medication and lacked any post randomization data. Participants with data available were included.
KgLEAST_SQUARES_MEAN
SECONDARYRate of Response for Completing 400 MW Test After 6 MonthsBaseline and 6 Months
Full Analysis Set: Population consists of randomized participants, excluding participants who failed to take at least one dose of trial medication and had a very early withdrawal (first week after randomization) definitely not related to study medication and lacked any post randomization data. Participants with rate of response for completing 400 MW test were included in the analysis.
ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYChange From Baseline to 6 Months in Muscle Strength Based on Knee ExtensionBaseline and 6 Months
Full Analysis Set: Population consists of randomized participants, excluding participants who failed to take at least one dose of trial medication and had a very early withdrawal (first week after randomization) definitely not related to study medication and lacked any post randomization data. This data represents Knee Extension of Highest Reading from all Degrees. Participants with data available were included.
Newton meter (Nm)LEAST_SQUARES_MEAN
SECONDARYChange From Baseline to 6 Months in Time for Five Chair Stands as Part of the Short Physical Performance Battery (SPPB) AssessmentBaseline and 6 Months
Full Analysis Set: Population consists of randomized participants, excluding participants who failed to take at least one dose of trial medication and had a very early withdrawal (first week after randomization) definitely not related to study medication and lacked any post randomization data. Participants with data available were included.
SecondsLEAST_SQUARES_MEAN
SECONDARYChange From Baseline to 6 Months in Distance in the 6-Minute Walk Test (6MWT)Baseline and 6 Months
Full Analysis Set: Population consists of randomized participants, excluding participants who failed to take at least one dose of trial medication and had a very early withdrawal (first week after randomization) definitely not related to study medication and lacked any post randomization data. Participants with data available were included.
MetersLEAST_SQUARES_MEAN
SECONDARYChange From Baseline to 6 Months in Pepper Assessment Tool for Disability (PAT-D) for Obese ParticipantsBaseline and 6 Months
Full Analysis Set: Population consists of randomized participants, excluding participants who failed to take at least one dose of trial medication and had a very early withdrawal (first week after randomization) definitely not related to study medication and lacked any post randomization data. Participants with data available were included.
score on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline to 6 Months in SPPB Total ScoreBaseline and 6 Months
Full Analysis Set: Population consists of randomized participants, excluding participants who failed to take at least one dose of trial medication and had a very early withdrawal (first week after randomization) definitely not related to study medication and lacked any post randomization data. Participants with data available were included.
score on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline to 6 Months in Sarcopenia Quality of Life (SarQoL) Auto-Evaluation QuestionnaireBaseline and 6 Months
Full Analysis Set: Population consists of randomized participants, excluding participants who failed to take at least one dose of trial medication and had a very early withdrawal (first week after randomization) definitely not related to study medication and lacked any post randomization data. This data represents overall disability score. Participants with data available were included.
score on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline to 6 Months in Stair Climb Power Test (SCPT)Baseline and 6 Months
Full Analysis Set: Population consists of randomized participants, excluding participants who failed to take at least one dose of trial medication and had a very early withdrawal (first week after randomization) definitely not related to study medication and lacked any post randomization data. Participants with data available were included.
SecondsLEAST_SQUARES_MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03452488/outcomes